BioNTech (BNTX) Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization
The investment potential of BioNTech SE relies on the costly infrastructure of ultra-cold drug delivery chains. The EV/EBITDA trend over time visualizes the enterprise value, where the current value is 0.00. The biotech's prospects are based on its leadership in mRNA cancer therapy, although the lack of commercial products and massive R&D expenditures currently deprive the company of pricing power.
biontech.de - analytical breakdowns and key metrics (BNTX)
- current price and projected stock value:
- market capitalization details:
- book value of equity indicators:
- debt level and financial liquidity data:
- business earnings and investment ratios data:
BNTX - Company Net Income|Expected Profit BioNTech SE|BNTX - Price to Earnings Multiple|Projected Price to Earnings BioNTech SE|BNTX - Company Value to Earnings Growth Ratio|EV/EBITDA Multiple BioNTech Pharma|BNTX - Profit before interest, taxes and amortization|Net earnings per share (EPS TTM) BioNTech|BNTX - Net earnings per share for the last 12 months|Quarterly EPS earnings growth biontech.de|BNTX - Earnings per share increase in current year|Expected earnings per share growth for next year BioNTech SE
Initial company analysis:BioNTech Group BNTX
The EV/EBITDA ratio compares the total enterprise value with operating profit before depreciation and amortization, determining the business's payback period. The trend in calculated levels reflects market expectations regarding cash flow generation efficiency. By analyzing the EV/EBITDA chart against historical data, an investor can assess whether the asset is overbought. For BioNTech SE (BNTX), this metric is critical during the transition from pandemic-era revenues to investments in oncology therapies and mRNA projects.
Who BioNTech SE competes with
EV/EBITDA Multiple ARGX (Argenx)|Total Company Value to Operating Income Before Depreciation Ratio Abivax (ABVX)|ADMA - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|protagonist-inc.com (PTGX) - Enterprise Value to EBITDA Ratio|Immunovant (IMVT) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio Kiniksa Pharmaceuticals, Ltd.|Enterprise Value to EBITDA Ratio GRFS|EV/EBITDA Multiple Adaptive Biotechnologies Inc.|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Celldex Therapeutics (CLDX)|auriniapharma.com - Enterprise Value to Operating Income Before Depreciation|EV/EBITDA Multiple BCRX (BioCryst Pharmaceuticals)|Vera Therapeutics Inc (VERA) - Company Value to EBITDA|Dianthus Pharma - EV/EBITDA Multiple|PHVS: Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|ABCL: EV/EBITDA Multiple|TRML - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Precigen|Company Value to EBITDA Pharming Group NV PHAR|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Nektar (NKTR)|Upstream Pharma - Enterprise Value to Operating Income Before Depreciation|Zenas Biopharma Inc - Enterprise Value to EBITDA Ratio|Enterprise Value to Operating Income Before Depreciation Ratio IMNM (immunome.com)|Gossamer Bio - EV/EBITDA Multiple|Company Value to EBITDA KalVista Pharma|SEPN: EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio Pieris Corp|SVRA (Savara Inc.) - EV/EBITDA Multiple|RIGL: Business Value to Operating Income Before Depreciation|Enterprise Value to EBITDA Ratio ANAB (AnaptysBio)|ATXS (Astria Therapeutics Inc) - Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization enGene Bio ENGN|Total Company Value to Operating Income Before Depreciation Ratio rapt.com (RAPT)|Aerovate - EV/EBITDA Multiple|Company Value to EBITDA aclaristx.com|KYTX: EV/EBITDA Multiple|TLSA (Tiziana Life Sciences Ltd.) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Cabaletta Bio, Inc|Enterprise Value to Operating Income Before Depreciation VTYX (Ventyx Biosciences, Inc)|Enterprise Value to EBITDA Ratio THTX (Theratechnologies Inc.)|Enterprise Value to Operating Income Before Depreciation Ratio AVTX|Eledon Pharmaceuticals, Inc. - Enterprise Value to EBITDA Ratio|AGEN: Enterprise Value to Operating Income Before Depreciation|CLYM - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to Operating Income Before Depreciation Ratio ZURA|ATYR: EV/EBITDA Multiple|Adagene Inc. - Business Value to Operating Income Before Depreciation|IMA (ImageneBio) - EV/EBITDA Multiple|EV/EBITDA Multiple Shattuck Therapeutics|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Equillium, Inc. (EQ)|CNTB (connectbiopharm.com) - Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Immunic IMUX|ATRA - Enterprise Value to EBITDA Ratio|InflaRx GmbH - EV/EBITDA Multiple|XFOR - EV/EBITDA Multiple|ACET (adicetbio.com) - Enterprise Value to EBITDA Ratio|Celularity - Business Value to Operating Income Before Depreciation|INMB (INmune Bio, Inc.) - EV/EBITDA Multiple|barinthusbio.com (BRNS) - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Kezar Life Sciences, Inc. (KZR)|Enterprise Value to EBITDA Ratio SAB Biotherapeutics Inc. SABS|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Akari Therapeutics plc AKTX|ENLV - Enterprise Value to EBITDA Ratio|QTTB: Enterprise Value to EBITDA Ratio|GOVX - EV/EBITDA Multiple|Edesa Biotech (EDSA) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to Operating Income Before Depreciation IBIO|CARM (Carisma Therapeutics Inc) - EV/EBITDA Multiple|Company Value to EBITDA XTL Bio XTLB|EV/EBITDA Multiple BOLT|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization HCWB (hcwbiologics.com)|EV/EBITDA Multiple APVO (Aptevo Therapeutics Inc.)|Total Company Value to Operating Income Before Depreciation Ratio aimimmuno.com (AIM)|ADTX - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to EBITDA GRI Bio Corporation|XORTX Therapeutics Inc. (XRTX) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to Operating Income Before Depreciation HIND|Enterprise Value to EBITDA Ratio REVB|INDP (Indaptus Therapeutics Inc) - Enterprise Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple SCNI|CALI - Company Value to EBITDA|EV/EBITDA Multiple AFMD (Affimed N.V.)|ALLK - Enterprise Value to EBITDA Ratio|HOOKIPA - EV/EBITDA Multiple|Business Value to Operating Income Before Depreciation IGMS (IGM Biosciences, Inc.)|ITOS (iTeos) - Enterprise Value to EBITDA Ratio|Ocean Biomedical Corp - Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization TC Biopharm|thirdharmonicbio.com (THRD) - Total Company Value to Operating Income Before Depreciation Ratio
